Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Alliance Pharma Plc (APH) Ordinary 1p

Sell:104.80p Buy:105.20p 0 Change: 4.00p (3.96%)
FTSE AIM 100:0.53%
Market closed Prices as at close on 21 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 4.00p (3.96%)
Market closed Prices as at close on 21 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Change: 4.00p (3.96%)
Market closed Prices as at close on 21 September 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international. The Company's therapeutic areas of focus include cardiovascular, central nervous system, child health, consumer health, dermatology, endocrinology, gastroenterology, obstetrics and gynecology, oral health, oncology, stoma care, toxicology and travel health. The Company's product categories include prescription only medicines, over the counter medications, medical devices, cosmetics and nutritional supplements. The Company's products include SkinSafe, Lift Plus, AbsorbaGel, DeoGel, LaVera, ClearWay, Gelclair, ImmuCyst 81mg, Hydromol, MacuShield, Lypsyl, Anbesol Adult Strength Gel, MolluDab and Ashton & Parsons Infants' Powders.

Contact details

Avonbridge House, Bath Road
SN15 2BB
United Kingdom
+44 (01249) 466966

Important dates

Future events
There are no future events available.
Past events
Interim results 21 September 2021 21/09/21
Trading Announcement 20 July 2021 20/07/21
Final dividend payment date 08 July 2021 08/07/21
Final ex-dividend date 10 June 2021 10/06/21
AGM 19 May 2021 19/05/21
Annual report 09 April 2021 09/04/21
Annual report 29 March 2021 29/03/21
Final results 23 March 2021 23/03/21
Trading Announcement 20 January 2021 20/01/21
Interim dividend payment date 07 January 2021 07/01/21
Interim ex-dividend date 17 December 2020 17/12/20
Interim results 22 September 2020 22/09/20

General stock information

Market cap:
£562.80 million
Shares in issue:
536.00 million
Pharmaceuticals & Biotechnology
London Stock Exchange
Sterling pence

Key personnel

  • Peter Butterfield
    Chief Executive Officer, Executive Director
  • Andrew Franklin
    Chief Financial Officer, Executive Director
  • Stephen Kidner
    Chief Scientific and Operations Officer
  • Janice Timberlake
    Chief People and Infrastructure Officer
  • Alex Duggan
    Chief Commercial Officer
  • Dan Thomas
    Chief Corporate Development Officer
  • Chris Chrysanthou
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.